Brown & Brown (BRO) is down roughly 3% in the latest session, with the move aligning with a cluster of fresh analyst price-target cuts over the last several days. JPMorgan lowered its target to $85 from $91 while keeping a Neutral rating on April 9, and Barclays cut its target to $72 from $80 on April 10, adding to the near-term negative tone around the name.

The target cuts are landing as investors position for Brown & Brown’s next earnings catalyst: the company is scheduled to report Q1 2026 results on April 27. With the stock already off its late-March range, additional downward revisions to valuation assumptions and peer-multiple resets can drive incremental selling, especially in a tape where investors have been quick to fade premium-valued financials and insurance distributors.

Key near-term signposts are (1) any further target reductions or rating changes, (2) management commentary around organic revenue growth and expense discipline, and (3) whether the stock can stabilize around recent support after this week’s selloff. Investors will also scrutinize updates around integration and execution, as well as any incremental disclosures; the company filed an 8-K dated April 8, 2026 tied to the release of its annual Global Impact Report.